Conatumumab

DB11646InvestigationalProtein Based Therapies

Conatumumab has been used in trials studying the treatment of Sarcoma, Lymphoma, Oncology, Colon Cancer, and Rectal Cancer, among others.

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 10B
Curator reviewed
Code names: AMG-655

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

420Drug interactionsStructured to mechanism, not free text

11Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Conatumumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.